Gilberto Fisone

Affiliations: 
Neuroscience Karolinska Institute, Stockholm, Sweden 
Google:
"Gilberto Fisone"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Masini D, Bonito-Oliva A, Bertho M, et al. (2018) Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's Disease. Frontiers in Neurology. 9: 208
Caggiano V, Leiras R, Goñi-Erro H, et al. (2018) Midbrain circuits that set locomotor speed and gait selection. Nature
Fürth D, Vaissière T, Tzortzi O, et al. (2017) Publisher Correction: An interactive framework for whole-brain maps at cellular resolution. Nature Neuroscience
Fürth D, Vaissière T, Tzortzi O, et al. (2017) An interactive framework for whole-brain maps at cellular resolution. Nature Neuroscience
di Val Cervo PR, Romanov RA, Spigolon G, et al. (2017) Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nature Biotechnology
Bonito-Oliva A, Södersten E, Spigolon G, et al. (2016) Differential Regulation of the Phosphorylation of Trimethyl-lysine27 Histone H3 at Serine 28 in Distinct Populations of Striatal Projection Neurons. Neuropharmacology
Bastide MF, Meissner WG, Picconi B, et al. (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology
Fuxe K, Borroto-Escuela D, Fisone G, et al. (2014) Understanding the role of heteroreceptor complexes in the central nervous system. Current Protein & Peptide Science. 15: 647
Södersten E, Feyder M, Lerdrup M, et al. (2014) Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism. Plos Genetics. 10: e1004574
Bonito-Oliva A, Masini D, Fisone G. (2014) A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions. Frontiers in Behavioral Neuroscience. 8: 290
See more...